HEALTHCARE FINDS 100 DMA SUPPORT – IS FANG & NOSH NEXT?
HEALTHCARE FINDS 100 DMA SUPPORT – IS FANG & NOSH NEXT? As Bloomberg notes, valuations are a notoriously poor tool for market timing, and forward earnings estimates could prove to be too low, so this alone shouldn’t necessarily serve as a sell signal. However, notice the divergence in fortunes between tech and health care that’s […]